ID: ALA5283833

Max Phase: Preclinical

Molecular Formula: C37H51NO8

Molecular Weight: 637.81

Associated Items:

Representations

Canonical SMILES:  CC(C)=C[C@H]1O[C@H]2[C@H]3O[C@@]34[C@H](CC[C@@]3(C)[C@@]4(O)CC[C@H]4C[C@@]5(O)c6c(CC7OC7(C)C)cccc6N[C@@]5(O)[C@@]43C)O[C@@H]2C(C)(C)O1

Standard InChI:  InChI=1S/C37H51NO8/c1-19(2)16-25-43-27-28(31(5,6)45-25)42-23-13-14-32(7)33(8)21(12-15-35(32,40)36(23)29(27)46-36)18-34(39)26-20(17-24-30(3,4)44-24)10-9-11-22(26)38-37(33,34)41/h9-11,16,21,23-25,27-29,38-41H,12-15,17-18H2,1-8H3/t21-,23-,24?,25-,27+,28-,29+,32+,33-,34+,35-,36-,37+/m0/s1

Standard InChI Key:  PYSWWYGVLWQSNR-QWIUXTLFSA-N

Associated Targets(Human)

Acyl coenzyme A:cholesterol acyltransferase 1 857 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Acyl coenzyme A:cholesterol acyltransferase 2 288 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 637.81Molecular Weight (Monoisotopic): 637.3615AlogP: 4.45#Rotatable Bonds: 3
Polar Surface Area: 125.47Molecular Species: NEUTRALHBA: 9HBD: 4
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.97CX Basic pKa: CX LogP: 4.57CX LogD: 4.57
Aromatic Rings: 1Heavy Atoms: 46QED Weighted: 0.28Np Likeness Score: 1.77

References

1. Bhattacharjee P, Rutland N, Iyer MR..  (2022)  Targeting Sterol O-Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): A Perspective on Small-Molecule Inhibitors and Their Therapeutic Potential.,  65  (24.0): [PMID:36473091] [10.1021/acs.jmedchem.2c01265]

Source